Key Points
GREEN.BR stock flat at €7.22 with extreme oversold technical signals
Meyka AI forecasts €7.58 year-end, €10.85 five-year target
Valuation discount at 0.066 price-to-sales offers downside protection
Volume collapse to 3.8% of average signals capitulation and bounce setup
GREEN.BR stock remains flat at €7.22 on EURONEXT as of April 28, 2026. Greenyard NV, the Belgium-based food distribution company, shows classic oversold bounce signals after recent weakness. The stock trades near its 50-day moving average of €7.32, with volume at just 1,552 shares against a 40,671 average. Trading activity has dried up significantly, creating potential for a reversal. Meyka AI’s analysis platform identifies this as a critical technical setup for investors monitoring GREEN.BR stock in the Consumer Defensive sector.
GREEN.BR Stock Price Action and Technical Setup
GREEN.BR stock trades at €7.22 with zero daily change, sitting between its day low of €7.00 and day high of €7.22. The year-to-date performance shows strength at +35.71%, though the stock remains 16.45% above its one-year low of €4.74. Year-high stands at €7.42, just 2.8% above current levels.
The technical picture reveals oversold conditions. RSI reads at zero, indicating extreme weakness. ADX at 50.00 signals a strong downtrend, while Keltner Channels show the stock trading near the middle band at €7.27. Volume has collapsed to just 1,552 shares, representing only 3.8% of the 40,671-share average. This extreme low volume combined with oversold indicators creates the classic setup for an oversold bounce.
Greenyard NV Fundamentals and Valuation Metrics
Greenyard NV operates across 85,000 employees in fresh and frozen food distribution across Europe. The company shows mixed financial health with a market cap of €355.3 million and enterprise value of €809.4 million.
Valuation metrics reveal deep discounts. The price-to-sales ratio sits at just 0.066, among the lowest in the sector. Price-to-book stands at 0.82, suggesting the stock trades below tangible asset value. However, profitability remains challenged with negative earnings per share of -€0.09 and a negative PE ratio. Free cash flow yield of 0.37% and operating cash flow per share of €3.88 show the company generates cash despite net losses. Track GREEN.BR on Meyka for real-time updates on these fundamental shifts.
Market Sentiment and Trading Activity Analysis
Trading Activity: Volume has collapsed dramatically to 1,552 shares, down 96.2% from the 40,671-share average. This extreme illiquidity signals capitulation, a classic sign of oversold conditions. Money Flow Index at 50.00 shows neutral momentum, while On-Balance Volume reads negative at -1,552, reflecting selling pressure exhaustion.
Liquidation Signals: The stock’s 35.71% year-to-date gain masks recent weakness. Three-month performance shows -0.82% decline, indicating profit-taking. Debt-to-equity ratio of 1.36 and current ratio of 0.80 reveal financial stress, yet the extreme valuation discount and dried-up volume suggest forced selling has ended. Relative volume at just 3.8% of average indicates institutional interest has vanished, creating a potential vacuum for reversal.
Meyka AI Grade and Price Forecast for GREEN.BR Stock
Meyka AI rates GREEN.BR with a grade of B and a HOLD recommendation based on a score of 69.68. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating reflects neutral fundamentals with mixed signals across profitability and valuation.
Meyka AI’s forecast model projects €7.58 for year-end 2026, representing 5.0% upside from current levels. The three-year forecast reaches €9.22, implying 27.7% total return. Five-year projections target €10.85, suggesting 50.1% long-term appreciation. These forecasts are model-based projections and not guarantees. The oversold technical setup combined with modest upside targets creates a risk-reward scenario favoring patient investors.
Final Thoughts
GREEN.BR stock presents a textbook oversold bounce opportunity at €7.22 on EURONEXT. Extreme technical weakness, collapsed volume, and deep valuation discounts create conditions for reversal. Greenyard NV’s 0.066 price-to-sales ratio and 0.82 price-to-book value suggest significant downside protection. However, negative earnings and debt concerns require caution. Meyka AI’s B grade and HOLD rating reflect balanced risk. The year-end forecast of €7.58 offers modest upside, while the five-year target of €10.85 rewards patient capital. Investors should monitor volume recovery as the first confirmation signal of a genuine bounce. These grades are not guaranteed and we are not financial advisors.
FAQs
GREEN.BR displays extreme oversold conditions with RSI at zero, ADX at 50 showing strong downtrend, and volume collapsed to just 3.8% of average. This exhaustion typically precedes reversals. The stock trades near support at €7.00, creating a technical setup for bounce.
Meyka AI forecasts €7.58 for year-end 2026 (5% upside), €9.22 in three years (27.7% upside), and €10.85 in five years (50.1% upside). These are model-based projections, not guarantees. Current price of €7.22 offers modest entry for long-term investors.
Greenyard NV reports negative earnings per share of -€0.09 and no dividend payments. The company generates positive operating cash flow of €3.88 per share but faces profitability challenges. Debt-to-equity of 1.36 indicates financial stress requiring monitoring.
Meyka AI’s B grade with HOLD recommendation reflects neutral fundamentals. The 69.68 score factors in sector comparison, financial growth, and key metrics. This suggests balanced risk-reward without strong conviction for buying or selling at current levels.
Volume collapsed to 1,552 shares versus 40,671 average, representing 96.2% decline. This extreme illiquidity suggests institutional selling has ended and retail interest remains minimal. Low volume increases bounce volatility but signals capitulation completion.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)